Impact of PNPLA3 I148M on alpha-1 antitrypsin deficiency-dependent liver disease progression
I Volkert, M Fromme, C Schneider, L Candels… - Hepatology, 2024 - journals.lww.com
Impact of PNPLA3 I148M on alpha-1 antitrypsin deficiency-dep... : Hepatology Impact of
PNPLA3 I148M on alpha-1 antitrypsin deficiency-dependent liver disease progression …
PNPLA3 I148M on alpha-1 antitrypsin deficiency-dependent liver disease progression …
Abdominal fat interacts with PNPLA 3 I148M, but not with the APOC 3 variant in the pathogenesis of liver steatosis in chronic hepatitis C
R Zampino, N Coppola, G Cirillo… - Journal of Viral …, 2013 - Wiley Online Library
The patatin‐like phospholipase domain‐containing 3 gene (PNPLA 3) and the
apolipoprotein C3 gene (APOC 3) have been studied in relation to liver steatosis and liver …
apolipoprotein C3 gene (APOC 3) have been studied in relation to liver steatosis and liver …
PNPLA3 148M Carriers with Inflammatory Bowel Diseases Have Higher Susceptibility to Hepatic Steatosis and Higher Liver Enzymes
RM Mancina, R Spagnuolo, M Milano… - Inflammatory Bowel …, 2016 - academic.oup.com
Background Inflammatory bowel diseases (IBD) are characterized by chronic relapsing
inflammation of the gastrointestinal tract and encompass Crohn's disease and ulcerative …
inflammation of the gastrointestinal tract and encompass Crohn's disease and ulcerative …
[HTML][HTML] Patatin-like phospholipase domain containing-3 gene I148M polymorphism, steatosis, and liver damage in hereditary hemochromatosis
L Valenti, P Maggioni, A Piperno… - World Journal of …, 2012 - ncbi.nlm.nih.gov
AIM: To investigate whether the patatin-like phospholipase domain containing-3 gene
(PNPLA3) I148M polymorphism is associated with steatosis, fibrosis stage, and cirrhosis in …
(PNPLA3) I148M polymorphism is associated with steatosis, fibrosis stage, and cirrhosis in …
Steatosis is an independent predictor of relapse following rapid virologic response in patients with HCV genotype 3
SR Shah, K Patel, P Marcellin, GR Foster… - Clinical …, 2011 - Elsevier
BACKGROUND & AIMS: It is recommended that patients with chronic hepatitis C virus (HCV)
genotype 3 infections receive 24 weeks of treatment. A rapid virologic response (RVR; at …
genotype 3 infections receive 24 weeks of treatment. A rapid virologic response (RVR; at …
Patatin-like phospholipase domain containing 3 sequence variant and hepatocellular carcinoma
We read with interest the reviews by Ghouri et al. 1 and Martinez et al. 2 Ghouri et al.
analyzed the association of nonalcoholic fatty liver disease (NAFLD) with cardiovascular …
analyzed the association of nonalcoholic fatty liver disease (NAFLD) with cardiovascular …
The role of mitochondrial genomics in patients with non-alcoholic steatohepatitis (NASH)
Background Visceral obesity and metabolic syndrome are commonly associated with non-
alcoholic fatty liver disease (NAFLD). The progression of steatosis to NASH depends on a …
alcoholic fatty liver disease (NAFLD). The progression of steatosis to NASH depends on a …
[PDF][PDF] DEPDC5 variants increase fibrosis progression in Europeans with chronic hepatitis C virus infection
Chronic hepatitis C virus (HCV) infection may progress to cirrhosis and hepatocellular
carcinoma (HCC). Recently, two genetic variants, DEPDC5 rs1012068 and MICA …
carcinoma (HCC). Recently, two genetic variants, DEPDC5 rs1012068 and MICA …
Polymorphisms in MICA, but not in DEPDC5, HCP5 or PNPLA3, are associated with chronic hepatitis C-related hepatocellular carcinoma
Recently, the MICA rs2596542 and DEPDC5 rs1012068 variants in Japanese individuals as
well as the HCP5 rs2244546 and PNPLA3 rs738409 variants in European individuals have …
well as the HCP5 rs2244546 and PNPLA3 rs738409 variants in European individuals have …
The impact of PNPLA3 (rs738409 C>G) polymorphisms on liver histology and long‐term clinical outcome in chronic hepatitis B patients
WP Brouwer, AJ van der Meer, A Boonstra… - Liver …, 2015 - Wiley Online Library
Abstract Background & Aims We aimed to assess the association between the patatin‐like
phospholipase domain‐containing‐3 (PNPLA 3) I148M polymorphism, liver histology and …
phospholipase domain‐containing‐3 (PNPLA 3) I148M polymorphism, liver histology and …